Intercell receives CHMP positive opinion for the pediatric indication of its Japanese Encephalitis vaccine in Europe

Press Wire ♦ Published: December 19, 2012; 09:00 ♦ (Vindobona)

Intercell receives CHMP positive opinion for the pediatric indication of its Japanese Encephalitis vaccine in Europe

Intercell receives CHMP positive opinion for the pediatric indication of its Japanese Encephalitis vaccine in Europe / Picture: © Vindobona.org
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement.

Company Information

Wien (euro adhoc) - Vienna (Austria), December 19, 2012 - Intercell AG (VSE;
"ICLL") today announced that the CHMP of the European Medicines Agency (EMA) has
come to a positive opinion on the Marketing…

or Log In

Fast News Search
Read More
Intercell
ISIN
AT0000612601
Featured
See latest Vindobona Newsletter